EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Therapie, 70 2 (2015) 113-122 Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?

Célian Bertin, Edouard Montigne, Sarah Teixeira, Florent Ferrer, Louis Lauwerie, Damien Richard and Nicolas Authier
Harm Reduction Journal 20 (1) (2023)
https://doi.org/10.1186/s12954-023-00781-2

Évaluation du potentiel d’abus et de dépendance de la quétiapine (Xeroquel®)

Hélène Peyrière, Caroline Diot, Céline Eiden and Pierre Petit
Therapies 78 (5) S41 (2023)
https://doi.org/10.2515/therapie/2015048

Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021

Bruno Revol, Théo Willeman, Marc Manceau, Véronique Dumestre-Toulet, Jean-Michel Gaulier, Nathalie Fouilhé Sam-Laï, Hélène Eysseric-Guérin, Chadi Abbara, Delphine Allorge, Jean-Claude Alvarez, Alice Ameline, Aurélie Aquizerate, Anne Barret, Emilie Berland, Célian Bertin, Thierry Besnard, Fabien Bevalot, Camille Billet-Chatenay, Emilie Bouquet, Joanna Bourgine, Bertrand Brunet, Anne-Sylvie Caous, Alexandre Cesbron, Leila Chaouachi, Cécile Chevallier, et al.
JAMA Network Open 6 (8) e2331398 (2023)
https://doi.org/10.1001/jamanetworkopen.2023.31398

Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?

Sandra Nordmann, Thomas Nefau, Joëlle Micallef, Catherine Duplessy, Jean-Christophe Catusse and Elisabeth Frauger
Therapies 78 (5) S51 (2023)
https://doi.org/10.2515/therapie/2015054

Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings

Ruben Goncalves, Magali Labadie, Simon Chouraqui, Alexandre Peyré, Nadège Castaing, Amélie Daveluy and Mathieu Molimard
Clinical Toxicology 60 (4) 458 (2022)
https://doi.org/10.1080/15563650.2021.1994144

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Edouard-Jules Laforgue, Marion Istvan, Benoit Schreck, Marie Mainguy, Pascale Jolliet, Marie Grall-Bronnec and Caroline Victorri-Vigneau
Journal of Clinical Medicine 11 (8) 2176 (2022)
https://doi.org/10.3390/jcm11082176

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels

Bérenger Largeau, Arnaud Karam, Camille Potey, Anne‐Sylvie Caous, Céline Tard, Louise Carton, Grégory Kuchcinski, Sophie Gautier, Sylvie Deheul and Régis Bordet
European Journal of Neurology 29 (8) 2173 (2022)
https://doi.org/10.1111/ene.15370

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users

Edouard-Jules Laforgue, Morgane Rousselet, Antoine Claudon, Aurélie Aquizerate, Pascale Jolliet, Marion Istvan and Caroline Victorri-Vigneau
International Journal of Environmental Research and Public Health 19 (15) 8920 (2022)
https://doi.org/10.3390/ijerph19158920

Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017)

Emilie Bouquet, Stéphanie Pain, Céline Eiden, Emilie Jouanjus, Nathalie Richard, Bernard Fauconneau and Marie‐Christine Pérault‐Pochat
British Journal of Clinical Pharmacology 87 (10) 3925 (2021)
https://doi.org/10.1111/bcp.14812

Management of Pregabalin Use Disorder: A Case Series

Lisa Langlumé, Céline Eiden, Sophie Roy, Floriane Taruffi, Julien Gambier, Hélène Donnadieu-Rigole and Hélène Peyrière
Journal of Psychoactive Drugs 1 (2021)
https://doi.org/10.1080/02791072.2021.2013579

Health consequences of cocaine use in France: data from the French Addictovigilance Network

Céline Eiden, Marc Vincent, Chris Serrand, Anais Serre, Nathalie Richard, Marie‐Christine Picot, Elisabeth Frauger, Nathalie Fouilhé, Amélie Daveluy and Hélène Peyrière
Fundamental & Clinical Pharmacology 35 (2) 455 (2021)
https://doi.org/10.1111/fcp.12603

Ten‐year trend of opioid and nonopioid analgesic use in the French adult population

Amélie Daveluy, Joëlle Micallef, Paola Sanchez‐Pena, Ghada Miremont‐Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Virginie Corand, Caroline Victorri‐Vigneau, Anne Batisse, Reynald Le Boisselier, Hélène Peyrière, Elisabeth Frauger, Maryse Lapeyre‐Mestre and Françoise Haramburu
British Journal of Clinical Pharmacology 87 (2) 555 (2021)
https://doi.org/10.1111/bcp.14415

Use of new psychoactive substances to mimic prescription drugs: The trend in France

Anne Batisse, Celine Eiden, Helene Peyriere and Samira Djezzar
NeuroToxicology 79 20 (2020)
https://doi.org/10.1016/j.neuro.2020.03.015

Serious Complications Associated With the Injection of Ethylphenidate

Sophie Roy, Robin Charreteur, Marie Gerardin, et al.
Journal of Clinical Psychopharmacology 40 (1) 87 (2020)
https://doi.org/10.1097/JCP.0000000000001167

Le mésusage du fentanyl en France : 2010 à 2015

Juliana Tournebize, Valérie Gibaja, Elisabeth Frauger, Nicolas Authier, Dominique Seyer, Joëlle Perri-Plandé, Audrey Fresse, Pierre Gillet, Lucie Javot and Jean-Pierre Kahn
Therapies 75 (5) 491 (2020)
https://doi.org/10.1016/j.therap.2019.11.002

The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisoners

Marion Mongiatti, Paule Bayle, Aude Lagarrigue, et al.
Therapies 75 (6) 579 (2020)
https://doi.org/10.1016/j.therap.2020.06.017

Clomiphene misuse and risk of severe cardiovascular events

Céline Eiden, Véronique Pinzani, Marion Laureau, et al.
European Journal of Clinical Pharmacology 76 (6) 901 (2020)
https://doi.org/10.1007/s00228-020-02858-4

Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)

Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, Amélie Daveluy and Françoise Haramburu
Therapies 74 (3) 375 (2019)
https://doi.org/10.1016/j.therap.2018.07.007

Détection des signaux du réseau français d’addictovigilance : méthodes innovantes d’investigation, illustrations et utilité pour la santé publique

Joëlle Micallef, Émilie Jouanjus, Michel Mallaret and Maryse Lapeyre Mestre
Therapies 74 (6) 579 (2019)
https://doi.org/10.1016/j.therap.2019.09.005

Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution

Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-Mestre
Therapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078

French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol

Marie Gérardin, Morgane Rousselet, Pascal Caillet, et al.
BMJ Open 9 (6) e027443 (2019)
https://doi.org/10.1136/bmjopen-2018-027443

Améliorer la balance bénéfices/risques de la méthadone en respectant ses spécificités pharmacologiques

Elisabeth Frauger, Nathalie Fouilhé Sam-Laï, Michel Mallaret and Joëlle Micallef
Therapies 74 (3) 383 (2019)
https://doi.org/10.1016/j.therap.2018.09.070

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Emilie Jouanjus, Joëlle Micallef, Michel Mallaret and Maryse Lapeyre-Mestre
International Journal of Neuropsychopharmacology 22 (8) 528 (2019)
https://doi.org/10.1093/ijnp/pyz033

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France

Anne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, Régis Lassalle, Caroline Dureau-Pournin, Cécile Droz-Perroteau, Annie Fourrier-Réglat, Francesco Salvo, Julien Bezin and Antoine Pariente
Therapies 74 (4) 469 (2019)
https://doi.org/10.1016/j.therap.2018.12.007

Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?

Maryse Lapeyre‐Mestre
Fundamental & Clinical Pharmacology 32 (6) 641 (2018)
https://doi.org/10.1111/fcp.12425

Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion

Emilie Jouanjus, Grégory Guernec and Maryse Lapeyre‐Mestre
Fundamental & Clinical Pharmacology 32 (3) 306 (2018)
https://doi.org/10.1111/fcp.12356

Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France

Liselotte Pochard, Julie Dupouy, Elisabeth Frauger, Adeline Giocanti, Joëlle Micallef and Maryse Lapeyre‐Mestre
Fundamental & Clinical Pharmacology 32 (2) 188 (2018)
https://doi.org/10.1111/fcp.12346

Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network

Céline Eiden, Sarah Leone‐Burgos, Anaïs Serre, Louise Carton, Marie Gerardin, Reynald Le Boisselier, Valérie Gibaja, Emilie Monzon, Nathalie Fouilhe, Alexandra Boucher and Hélène Peyriere
Fundamental & Clinical Pharmacology 32 (6) 654 (2018)
https://doi.org/10.1111/fcp.12395

Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries

Camille Ponté, Marion Lepelley, Quentin Boucherie, et al.
Drug and Alcohol Dependence 187 88 (2018)
https://doi.org/10.1016/j.drugalcdep.2018.01.036

Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study

Emilie Jouanjus, Alice Falcou, Sylvie Deheul, Anne Roussin and Maryse Lapeyre‐Mestre
Pharmacoepidemiology and Drug Safety 27 (11) 1286 (2018)
https://doi.org/10.1002/pds.4624

Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?

Gaétan Gentile, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus and Joëlle Micallef
Fundamental & Clinical Pharmacology 32 (6) 643 (2018)
https://doi.org/10.1111/fcp.12401

Implication de l’addictovigilance dans un service d’urgence pour la détection et le recueil des cas d’abus et de dépendance : bilan de 3 ans d’expérience

Anaïs Serre, Céline Eiden, Vincent Gourhant, et al.
Therapies 73 (6) 501 (2018)
https://doi.org/10.1016/j.therap.2018.06.002

Consommation de substances psychoactives à la Réunion et à Mayotte, départements français de l’Océan Indien

Amélie Daveluy and Françoise Haramburu
Therapies 73 (5) 419 (2018)
https://doi.org/10.1016/j.therap.2018.01.007

Tamper‐resistant prescription forms for narcotics in France: Should we generalize them?

Amélie Daveluy, Lucie Sauvaget, Angela Bastien, Maryse Lapeyre‐Mestre, Cédric Collin, Nathalie Richard and Françoise Haramburu
Fundamental & Clinical Pharmacology 32 (5) 571 (2018)
https://doi.org/10.1111/fcp.12368

Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital

Margaux Lafaurie, Liselotte Pochard, Clémence Lotiron, et al.
Clinical Drug Investigation 38 (10) 977 (2018)
https://doi.org/10.1007/s40261-018-0679-4

Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes

Elisabeth Frauger, Farid Kheloufi, Quentin Boucherie, et al.
Therapies 73 (6) 511 (2018)
https://doi.org/10.1016/j.therap.2018.07.001

Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey

Amélie Daveluy, Elisabeth Frauger, Hélène Peyrière, Christophe Moracchini, Françoise Haramburu and Joëlle Micallef
Fundamental & Clinical Pharmacology 31 (1) 126 (2017)
https://doi.org/10.1111/fcp.12233

High opioids tolerance due to transmucosal fentanyl abuse

Celine Eiden, Olivier Mathieu, Hélène Donnadieu-Rigole, Cécile Marrot and Hélène Peyrière
European Journal of Clinical Pharmacology 73 (9) 1195 (2017)
https://doi.org/10.1007/s00228-017-2272-9

Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter"

Emilie Jouanjus, Michel Mallaret, Joëlle Micallef, et al.
Drug Safety 40 (2) 183 (2017)
https://doi.org/10.1007/s40264-016-0497-7

Dispositif pharmacoépidémiologique de surveillance des substances psychoactives : intérêts du programme national OPPIDUM du Réseau français d’addictovigilance

Elisabeth Frauger, Liselotte Pochard, Quentin Boucherie, et al.
Therapies 72 (4) 491 (2017)
https://doi.org/10.1016/j.therap.2017.01.010

Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history

Damien Driot, Bruno Chicoulaa, Emilie Jouanjus, et al.
Therapies 71 (6) 575 (2016)
https://doi.org/10.1016/j.therap.2016.04.006

Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres

Hélène Peyrière, Céline Eiden, Michel Mallaret and Caroline Victorri-Vigneau
Therapies 71 (6) 563 (2016)
https://doi.org/10.1016/j.therap.2016.07.001

Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database

Jean-Baptiste Bossard, Camille Ponté, Julie Dupouy, Maryse Lapeyre-Mestre and Emilie Jouanjus
Clinical Drug Investigation 36 (9) 735 (2016)
https://doi.org/10.1007/s40261-016-0421-z

Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients

BMC Family Practice 17 (1) (2016)
https://doi.org/10.1186/s12875-016-0413-3